Predicting amyloid status in corticobasal syndrome using modified clinical criteria, magnetic resonance imaging and fluorodeoxyglucose positron emission tomography (2015)
- Authors:
- Autor USP: GRINBERG, LEA TENENHOLZ - FM
- Unidade: FM
- DOI: 10.1186/s13195-014-0093-y
- Subjects: DOENÇA DE ALZHEIMER; IMAGEM POR RESSONÂNCIA MAGNÉTICA; TOMOGRAFIA COMPUTADORIZADA POR EMISSÃO DE PÓSITRON (TENDÊNCIAS); DOENÇAS NEURODEGENERATIVAS
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Alzheimer's research & therapy
- Volume/Número/Paginação/Ano: v. 7, p. 8, 2015
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by
-
ABNT
SHA, Sharon J. et al. Predicting amyloid status in corticobasal syndrome using modified clinical criteria, magnetic resonance imaging and fluorodeoxyglucose positron emission tomography. Alzheimer's research & therapy, v. 7, p. 8, 2015Tradução . . Disponível em: https://doi.org/10.1186/s13195-014-0093-y. Acesso em: 19 set. 2024. -
APA
Sha, S. J., Ghosh, P. M., Lee, S. E., Rastelli, C. C., Jagust, W., Kormak, J., et al. (2015). Predicting amyloid status in corticobasal syndrome using modified clinical criteria, magnetic resonance imaging and fluorodeoxyglucose positron emission tomography. Alzheimer's research & therapy, 7, 8. doi:10.1186/s13195-014-0093-y -
NLM
Sha SJ, Ghosh PM, Lee SE, Rastelli CC, Jagust W, Kormak J, Rankin KP, Grinberg LT, Vinters HV, Mendez MF, Dickson DW, Seeley WW, Tempini MG, Kramer J, Boxer AL, Rabinovici GD. Predicting amyloid status in corticobasal syndrome using modified clinical criteria, magnetic resonance imaging and fluorodeoxyglucose positron emission tomography [Internet]. Alzheimer's research & therapy. 2015 ; 7 8.[citado 2024 set. 19 ] Available from: https://doi.org/10.1186/s13195-014-0093-y -
Vancouver
Sha SJ, Ghosh PM, Lee SE, Rastelli CC, Jagust W, Kormak J, Rankin KP, Grinberg LT, Vinters HV, Mendez MF, Dickson DW, Seeley WW, Tempini MG, Kramer J, Boxer AL, Rabinovici GD. Predicting amyloid status in corticobasal syndrome using modified clinical criteria, magnetic resonance imaging and fluorodeoxyglucose positron emission tomography [Internet]. Alzheimer's research & therapy. 2015 ; 7 8.[citado 2024 set. 19 ] Available from: https://doi.org/10.1186/s13195-014-0093-y - Challenges in Modern Biomarker Discovery – 17th HUPO BPP Workshop
- Progranulin Mutations as Risk Factors for Alzheimer Disease
- Distinct tau prion strain propagate in cells and mice and define different tauopathies
- In vivo signatures of nonfluent/agrammatic primary progressive aphasia caused by FTLD pathology
- FTD phenotype in AD due to argyrophilic thorny astrocyte clusters
- Distinct tau prion strains propagate in cells and mice and define different tauopathies
- Primary age-related tauopathy (PART): a common pathology associated with human aging
- Genetic modifiers in carriers of repeat expansions in the C90RF72 gene
- Longitudinal multimodal imaging and clinical endpoints for frontotemporal dementia clinical trials
- Alzheimer's disease clinical variants show distinct regional patterns of neurofibrillary tangle accumulation
Informações sobre o DOI: 10.1186/s13195-014-0093-y (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
